Trial Tuesday: ADCs And Method Marks In Madrid
Aakash Babu
4 min read
members
Aakash has covered the pharma sector since 2018, writing on everything from clinical trial successes to industry setbacks that offer lessons for those who follow. He enjoys travelling, supports Manchester United, and is an avid gamer.